MetLife (NYSE:MET - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Sunday, Wall Street Zen reports.
Other equities research analysts have also recently issued reports about the company. Mizuho increased their target price on MetLife from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Thursday. Piper Sandler upped their price target on shares of MetLife from $110.00 to $115.00 and gave the stock an "overweight" rating in a research note on Monday, November 9th. Morgan Stanley increased their price objective on shares of MetLife from $103.00 to $111.00 and gave the company an "overweight" rating in a research report on Monday, August 24th. TD Cowen raised their price objective on shares of MetLife from $110.00 to $114.00 and gave the company a "buy" rating in a research note on Wednesday, October 21st. Finally, Wells Fargo & Company lifted their target price on shares of MetLife from $110.00 to $113.00 and gave the stock an "overweight" rating in a report on Thursday. Fourteen investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $107.12.
Check Out Our Latest Stock Analysis on MetLife
MetLife Stock Up 0.8%
Shares of MET traded up $0.80 during mid-day trading on Friday, reaching $102.67. The company had a trading volume of 2,436,641 shares, compared to its average volume of 3,197,036. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.20 and a current ratio of 0.21. The company has a market capitalization of $64.52 billion, a price-to-earnings ratio of 13.39, a price-to-earnings-growth ratio of 0.96 and a beta of 0.79. The firm has a 50-day moving average price of $98.75 and a 200 day moving average price of $86.90. MetLife has a 52 week low of $67.33 and a 52 week high of $106.72.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.01. The company had revenue of $20.52 billion during the quarter, compared to analyst estimates of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The firm's revenue for the quarter was up 18.2% on a year-over-year basis. During the same quarter last year, the company earned $2.34 EPS. On average, sell-side analysts forecast that MetLife will post 9.91 EPS for the current year.
MetLife announced that its Board of Directors has approved a share repurchase program on Wednesday, August 5th that authorizes the company to repurchase $3 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its shares are undervalued.
Insider Buying and Selling at MetLife
In other news, CEO Michel Khalaf sold 187,425 shares of the business's stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the transaction, the chief executive officer directly owned 759,013 shares of the company's stock, valued at $78,155,568.61. The trade was a 19.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.40% of the stock is owned by insiders.
Institutional Investors Weigh In On MetLife
A number of hedge funds have recently added to or reduced their stakes in the stock. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of MetLife in the second quarter worth $26,000. Burk Holdings LLC bought a new position in MetLife in the second quarter valued at about $27,000. Nvwm LLC boosted its position in MetLife by 655.3% in the third quarter. Nvwm LLC now owns 287 shares of the financial services provider's stock worth $27,000 after purchasing an additional 249 shares during the last quarter. Highland Investment Advisors LLC purchased a new position in MetLife in the second quarter worth about $30,000. Finally, Meeder Asset Management Inc. grew its stake in shares of MetLife by 156.5% during the 3rd quarter. Meeder Asset Management Inc. now owns 354 shares of the financial services provider's stock valued at $33,000 after purchasing an additional 216 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
Key Stories Impacting MetLife
Investors following MET have been watching these stories:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
About MetLife
(
Get Free Report)
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.